Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$147K Sell
2,760
-1,600
-37% -$89.5K 0.14% 142
2014
Q3
$251K Sell
4,360
-3,652
-46% -$224K 0.24% 95
2014
Q2
$536K Hold
8,012
0.46% 73
2014
Q1
$536K Sell
8,012
-336
-4% -$22.7K 0.46% 76
2013
Q4
$557K Buy
8,348
+1,600
+24% +$104K 0.48% 75
2013
Q3
$423K Sell
6,748
-3,816
-36% -$246K 0.39% 88
2013
Q2
$660K Buy
+10,564
New +$670K 0.61% 51

Other funds holding GSK

Winifred I. Li's GSK Position: Q4 2014 in Review

Winifred I. Li reduced its GSK (GSK) stake by 37% in Q4 2014, selling an estimated $89.5K and leaving 2,760 shares worth $147K. The position accounts for 0.14% of the portfolio, ranked #142.

Winifred I. Li first reported a position in GSK in Q2 2013 and has held it in 7 quarters since. The position peaked at $660K in Q2 2013. 729 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • Winifred I. Li held 2,760 shares of GSK worth $147K as of Q4 2014.
  • Winifred I. Li sold 1,600 GSK shares in Q4 2014, an estimated $89.5K.
  • GSK made up 0.14% of Winifred I. Li's portfolio in Q4 2014, its #142 holding.
  • Winifred I. Li first reported a position in GSK in Q2 2013 and has held it in 7 quarters since.
  • Winifred I. Li's GSK position peaked at $660K in Q2 2013.
  • 729 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Winifred I. Li's 13F filing for Q4 2014, filed 19 Feb 2015.